Dimensionality of Parkinsonian signs in aging and Alzheimer's disease

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 54, Issue 4, 1999, Pages

  Bennett, David A ^a   Shannon, Kathleen M ^b   Beckett, Laurel A ^b   Wilson, Robert S ^b  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ALZHEIMER DISEASE; ARTICLE; FEMALE; FUNCTIONAL ASSESSMENT; GAIT DISORDER; HUMAN; MAJOR CLINICAL STUDY; MALE; MOTOR PERFORMANCE; PARKINSON DISEASE; PRIORITY JOURNAL; RIGIDITY; SEX DIFFERENCE; TREMOR;

PARKINSONIA;

EID: 0032913719     PISSN: 10795006     EISSN: None     Source Type: Journal    
DOI: 10.1093/gerona/54.4.M191     Document Type: Article

References (34)

1. Calne DB, Snow BJ, Lee C. Criteria for diagnosing Parkinson's disease. Ann Neurol. 1992;32:S125-S127.
2. Koller WC. How accurately can Parkinson's disease be diagnosed? Neurology. 1992;42(suppl 1):6-16.
3. Funkenstein HH, Albert MS, Cook NR, et al. Extrapyramidal signs and other neurologic findings in clinically diagnosed Alzheimer's disease. Arch Neurol. 1993;50:51-56.
4. Galasko D, Kwo-on-Yuen PF, Klauber MR, Thal LJ. Neurological findings in Alzheimer's disease and normal aging. Arch Neurol. 1990;47:625-627.
5. Kaye JA, Oken BS, Howieson DB, Howieson J, Holm LA, Dennison K. Neurologic evaluation of the optimally healthy oldest old. Arch Neurol. 1994;51:1205-1211.
6. Kokmen E, Bossemeyer RW, Barney J, Williams W. Neurological manifestations of aging. J Gerontol 1977;32:411-419.
7. Waite LM, Broe GA, Creasey H, Grayson D, Edelbrock D, O'Toole B. Neurological signs, aging, and the neurodegenerative syndromes. Arch Neurol. 1996;53:498-502.
8. Bennett DA, Beckett LA, Murray AM, et al. Prevalence of parkinsonian signs and associated mortality in a community population of older people. N Eng J Med. 1996;334:71-76.
9. Richards M, Stern Y, Marder K, Cote L, Mayeux R. Relationships between extrapyramidal signs and cognitive function in a community-dwelling cohort of patients with Parkinson's disease and normal elderly individuals. Ann Neurol. 1993;33:267-274.
10. Richards M, Stern Y, Mayeux R. Subtle extrapyramidal signs and incident dementia: follow-up analysis. Neurology. 1995;45:1942.
11. Stern Y, Tang MX, Albert M, et al. Predicting time to nursing home care and death in individuals with Alzheimer's disease. JAMA. 1997;277:806-812.
12. Lopez OL, Wisnieski SR, Becker JT, Boller F, DeKosky ST. Extrapyramidal signs in patients with probable Alzheimer's disease. Arch Neurol. 1997;54: 969-975.
13. Chui HC, Lyness SA, Sobel E, Schneider LS. Extrapyramidal signs and psychiatric symptoms predict faster cognitive decline in Alzheimer's disease. Arch Neurol. 1994;51:676-681.
14. Hershey LA, Feldman BJ, Kim KY, Commichau C, Lichter DG. Tremor at onset. Predictor of cognitive and motor outcome in Parkinson's disease. Arch Neurol. 1991;48:1049-1051.
15. Zetusky WJ, Jankovic J, Pirozzolo FJ. The heterogeneity of Parkinson's disease: clinical and prognostic implications. Neurology. 1985;35:522-526.
16. Louis ED, Marder K, Cote L, Tang M, Mayeux R. Mortality from Parkinson's disease. Arch Neurol. 1997;54:260-264.
17. Fahn S, Elton RL. Unified Parkinson's disease rating scale. In: Fahn S, Marsden CD, Calne DB, Goldstein M, eds. Recent Developments in Parkinson 's Disease, Vol 2. Florham Park, NJ: Macmillan Healthcare Information, 1987:153-163.
18. CAPIT Committee: Langston JW, Widner H, Goetz CG, et al. Core assessment program of intracerebral transplantation. Mov Disord. 1992;7:2-13.
19. de RiJk MC, Breteler MMB, Graveland GA, et al. Prevalence of Parkinson's disease in the elderly: the Rotterdam study. Neurology. 1995;45:2143-2146.
20. Parkinson Study Group. Effects of tocopherol and deprenyl on the progression of disability in early Parkinson's disease. N Engl J Med. 1993;328:176-183.
21. Jankovic J, McDermott M, Carter J, et al. Variable expression of Parkinson's disease: a baseline analysis of the DATATOP cohort. Neurology. 1990;40:1529-1534.
22. Folstein MF, Folstein SE McHugh PR. "Mini-Mental State": a practical method for grading the mental state of patients for the clinician. J Psychiatr Res. 1975;12:189-198.
23. Clark CM, Ewbank D, Lerner A, et al. The relationship between extrapyramidal signs and cognitive performance in patients with Alzheimer's disease enrolled in the CERAD study. Neurology. 1997;49:70-75.
24. Bennett DA, Shannon KM, Beckett LA, Goetz CG, Wilson RS. Metric properties of nurse's ratings of parkinsonian signs with a modified unified Parkinson's disease rating scale. Neurology. 1997;49:1580-1587.
25. Hartigan JA. Clustering Algorithms. New York: John Wiley & Sons; 1975.
26. Rand WM. Objective criteria for the evaluation of clustering methods. J Am Statist Assoc. 1971;66:846-850.
27. van Hilten JJ, van der Zwan AD, Zwinderman AH, Roos RAC. Rating impairment and disability in Parkinson's disease: evaluation of the Unified Parkinson's Disease Rating Scale. Mov Disord. 1994;9:84-88.
28. Richards M, Marder K, Cote L, Mayeux R. Interrater reliability of the Unified Parkinson's Disease Rating Scale motor examination. Mov Disord. 1994;9:89-91.
29. Richards M, Marder K, Bell K, Dooneief G, Mayeux R, Stern Y. Interrater reliability of extrapyramidal signs in a group assessed for dementia. Arch Neurol. 1991;48:1147-1149.
30. Vingerhoets FJ, Schulzer M, Calne DB, Snow BJ. Which clinical sign of Parkinson's disease best reflects the nigrostriatal lesion. Ann Neurol. 1997;41:58-64.
31. Drachman DA, O'Donnell BF, Lew RZ, Swearer JM. The prognosis in Alzheimer's disease. "How far" rather than "how fast" best predicts the course. Arch Neurol. 1990;47:851-856.
32. Bennett DA, Gilley DW, Wilson RS, Huckman MS, Fox JH. Clinical correlates of high signal lesions on magnetic resonance imaging in Alzheimer's disease. J Neurol. 1992;239:186-190.
33. Gilley DW, Wilson RS, Bennett DA, Bernard BA, Fox JH. Predictors of behavioral disturbance in Alzheimer's disease. J Gerontol Psych Sci. 1991;46:P362-P371.
34. Mortimer JA, Ebbitt B, Jun SP, Finch MD. Predictors of cognitive and functional progression in patients with probable Alzheimer's disease. Neurology. 1992;42:1689-1696.